MAPK10
MOLECULAR TARGETmitogen-activated protein kinase 10
MAPK10 (mitogen-activated protein kinase 10) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MAPK10
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | sp600125 | 3.18 | 23 |
| 2 | Quercetin | 1.61 | 4 |
| 3 | fisetin | 1.10 | 2 |
| 4 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.10 | 2 |
| 5 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.10 | 2 |
| 6 | Anisomycin | 1.10 | 2 |
| 7 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 8 | Afatinib | 0.69 | 1 |
| 9 | Axitinib | 0.69 | 1 |
| 10 | isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from | 0.69 | 1 |
| 11 | pictilisib | 0.69 | 1 |
About MAPK10 as a Drug Target
MAPK10 (mitogen-activated protein kinase 10) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented MAPK10 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MAPK10 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.